Voyager Therapeutics, Inc. (VYGR) has a consensus analyst rating of Buy, based on 21 analysts covering the stock. Of those, 17 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for VYGR is $14.40, representing a +263.4% upside from the current price of $3.963. Price targets range from a low of $8.00 to a high of $18.00.
